Advertisement

Supportive Care in Cancer

, Volume 27, Issue 3, pp 879–885 | Cite as

Sexual quality of life evaluation after treatment among women with breast cancer under 35 years old

  • Anaïse BlouetEmail author
  • Marie Zinger
  • Olivier Capitain
  • Sébastien Landry
  • Hugues Bourgeois
  • Valérie Thepot Seegers
  • Yoann Pointreau
Original Article

Abstract

Purpose

To qualify the quality of patients sexual lives after treatment among women with breast cancer under 35 years old and compare results to the literature.

Methods

Sexual quality of life was measured for 84 women aged 20 to 35 years old at diagnosis, with two validated quality of sexual life questionnaires, Brief Index of Sexual Functioning for Women (BISF-W) and Female Sexual Function Index (FSFI), at least six months after breast cancer diagnosis. Two other questionnaires were used to allow us to understand other aspects of their life before cancer and to monitor quality of sexual life during treatment.

Results

Forty-three women responded to the questionnaire. The questionnaires demonstrated that more than half of them had problems with their sexuality. The mean total score was 28.08/75 for BISF-W and 25.1 for FSFI (under the cutoff score 26.55). The domain analysis showed an association between the absence of chemotherapy and scores in regard to sexual health. Only 7% had sexual disturbance detected but 49% of the patients wished to have it.

Conclusion

Sexual dysfunction in breast cancer survivors is real, has several factors, and cannot be evaluated based only on the organic side effects induced by cancer treatment. Better monitoring and screening seems necessary in order to optimize the quality of sexual life after surviving breast cancer.

Keywords

Sexuality Sexual health Breast cancer BISF-W FSFI 

Abbreviations

FSFI

Female Sexual Function Index

BISF-W

Brief Index of Sexual Functioning for Women

ICO

insitut de cancérologie de l’OUEST

CJB

Centre Jean Bernard

Notes

Author’s contribution

Anaïse Blouet participated in conducting the study, collecting the data for the study, and in writing the manuscript.

Yoann Pointreau and Marie Zinger participated in the writing of the manuscript.

Valérie Thepot Seegers participated in the statistical analysis.

Olivier Capitain participated in revising the manuscript.

Hugues Bourgeois participated in revising the manuscript and in the construction of the study.

Sebastien Landry participated in revising the manuscript and in the construction of the study.

Funding information

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

This study obtained the agreement of the ethical committee from Angers University Hospital. All the authors are consent to publication. Informed consent was obtained from all individual participants included in the study. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Supplementary material

520_2018_4374_MOESM1_ESM.docx (14 kb)
ESM 1 (DOCX 13 kb)
520_2018_4374_MOESM2_ESM.docx (12 kb)
ESM 2 (DOCX 12 kb)
520_2018_4374_MOESM3_ESM.pdf (17 kb)
ESM 3 FSFI questionnaire (PDF 16 kb)
520_2018_4374_MOESM4_ESM.docx (1.1 mb)
ESM 4 BISF-W questionnaire (DOCX 1103 kb)

References

  1. 1.
    Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon. Available from: http://globocan.iarc.fr. Accessed 15 Jan 2018
  2. 2.
    Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36:237–248CrossRefGoogle Scholar
  3. 3.
    Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C (2012) The decline in breast cancer mortality in Europe: an update (to 2009). Breast Edinb Scotl 21:77–82CrossRefGoogle Scholar
  4. 4.
    Habold D, Bondil P (2014) L’intervention sexologique en oncologie. Presse Med 43:1120–1124CrossRefGoogle Scholar
  5. 5.
    Pinto AC (2013) Sexuality and breast cancer: prime time for young patients. J Thorac Dis 5(Suppl 1):S81–S86Google Scholar
  6. 6.
    Hannoun-Levi JM (2005) Treatment of breast and uterus cancer: physiological and psychological impact on sexual function. Cancer Radiother 9:175–182CrossRefGoogle Scholar
  7. 7.
    Habold D, Bondil P (2011) Cancer, vie et santé sexuelle. Référentiels inter régionaux en soins oncologiques de support, AFSOS. Available at: https://link.springer.com/content/pdf/10.1007%2Fs10269-011-2044-6.pdf
  8. 8.
    Préau M, Bouhnik AD, Le Coroller Soriano AG, ALD Cancer Study Group (2013) Two years after cancer diagnosis, what is the relationship between health-related quality of life, coping strategies and spirituality? Psychol Health Med. 18:375–386CrossRefGoogle Scholar
  9. 9.
    Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ (2005) Psychosocial issues confronting young women with breast cancer. Breast Dis 23:103–113CrossRefGoogle Scholar
  10. 10.
    Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD (2004) Functional impact of breast cancer by age at diagnosis. J Clin Oncol Off J Am Soc Clin Oncol 22:1849–1856CrossRefGoogle Scholar
  11. 11.
    Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 2001:44–51CrossRefGoogle Scholar
  12. 12.
    Caremel R, Berthier A, Sentilhes L, Collard P, Grise P (2008) Analyse de la sexualité féminine dans une population féminine témoin française. Prog Urol 18:527–535CrossRefGoogle Scholar
  13. 13.
    Shannon C, Smith IE (1990) Breast cancer in adolescents and young women. Eur J Cancer Oxf Engl 2003(39):2632–2642Google Scholar
  14. 14.
    Jooste V, Grosclaude P, Remontet L, Launoy G, Baldi I, Molinié F, Arveux P, Bossard N, Bouvier AM, Colonna M, the French Network of Cancer Registries (FRANCIM) (2013) Unbiased estimates of long-term net survival of solid cancers in France. Int J Cancer 132:2370–2377CrossRefGoogle Scholar
  15. 15.
    Ussher JM, Perz J, Gilbert E (2013) Information needs associated with changes to sexual well-being after breast cancer. J Adv Nurs 69:327–337CrossRefGoogle Scholar
  16. 16.
    Dargis L, Trudel G, Cadieux J, Villeneuve L, Préville M, Boyer R (2012) Validation of the female sexual function index (FSFI) and presentation of norms in older women. Theol Sex 21:126–131Google Scholar
  17. 17.
    Leroy T, Gabelle Flandin I, Habold D, Hannoun-Lévi J-M (2012) Impact de la radiothérapie sur la vie sexuelle. Cancer/Radiothérapie 16:377–385CrossRefGoogle Scholar
  18. 18.
    Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR (2006) Body image and sexual problems in young women with breast cancer. Psychooncology 15:579–594CrossRefGoogle Scholar
  19. 19.
    Bondil P, Habold D, Damiano T, Champsavoir P (2012) The personalized health care process in oncosexology: a new health care offer in the service of both patients and health carers. Bull Cancer (Paris) 99:499–507Google Scholar
  20. 20.
    Giuliano F (2013) Les questionnaires recommandés en médecine sexuelle. Prog Urol. 23:811–821CrossRefGoogle Scholar
  21. 21.
    Baudelot-Berrogain N, Roquejoffre S, Gamé X, Mallet R, Mouzin M, Bertrand N et al (2006) Linguistic validation of the “Brief Index of Sexual Functioning for Women”. Progres Urol 16:174–183Google Scholar
  22. 22.
    Giraldi A, Rellini A, Pfaus JG, Bitzer J, Laan E, Jannini EA, Fugl-Meyer AR (2011) Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med 8:2681–2706CrossRefGoogle Scholar
  23. 23.
    Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE (2002) Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75:241–248CrossRefGoogle Scholar
  24. 24.
    Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20CrossRefGoogle Scholar
  25. 25.
    Baser RE, Li Y, Carter J (2012) Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 118:4606–4618CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical OncologyCholet HospitalCholetFrance
  2. 2.Department of Oncology and AlgologyVictor Hugo Clinic-Jean Bernard CenterLe MansFrance
  3. 3.Department of Medical OncologyIntegrated Center of Oncology Paul PapinAngersFrance
  4. 4.Department of SexologyJean Bernard CenterLe MansFrance
  5. 5.Department of Medical OncologyVictor Hugo Clinic-Jean Bernard CenterLe MansFrance
  6. 6.Service de BiométrieIntegrated Center of Oncology Paul PapinAngersFrance
  7. 7.Department of Medical Oncology and RadiotherapyVictor Hugo Clinic-Jean Bernard CenterLe MansFrance

Personalised recommendations